The COVID-19 Pandemic – Products

This whitepaper evaluates the results of a study into the three main capping options available to manufacturers, highlighting expert insights on mRNA capping costs and customer needs.

Just – Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD’s Manufacturing Optimization Program.

New binders will be developed to multiple waterborne pathogens. Optimer will support continuous water monitoring for rapid detection.

PCR/qPCR solution will support surveillance and monitoring of the current H5N1 strain of bird flu in response to multi-state outbreak in U.S. dairy cows.

Zapnometinib is now ready for clinical development in severe influenza, an area without approved therapies and with a rapidly evolving pandemic threat from bird flu virus H5N1.

Fluidic Sciences Ltd., announces its official launch as a company, and the commercial relaunch of the acquired Fluidity One-M instrument for measuring protein-protein interactions in solution—leveraging Microfluidic Diffusional Sizing (MDS) technology.

TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) has announced the grand opening of its new cGMP mRNA manufacturing facility.

China shifts its focus to thermal imaging technologies, securing 50% of worldwide shipments in 2023.

With its Vivalytic analysis platform, Bosch has set itself the goal of making fast and highly precise diagnostics accessible at the point of care. To achieve this, Bosch has now agreed on a strategic partnership with Randox Laboratories Ltd.

This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.